Multi-Omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer

Runqiu Yi, Liying Xie, Xiaoqing Wang, Chengpin Shen, Xiaojun Chen, Liang QiaoFrontiers in Oncology 2022 · DOI

Abstract

With multi-omics characterization of multi-biosamples, the metabolomic changes related to EC are illustrated in a pathway-based way. The network of altered metabolites and related proteins provides a comprehensive view of altered metabolism in the endometrial tissue samples. The verification of these critical pathways by using urine and intrauterine brushing samples provides evidence for the possible non-invasive or minimally invasive biopsy for EC diagnosis in the future.

Introduction

Endometrial cancer (EC) is a leading gynecological malignancy. While histopathology remains the diagnostic "gold standard," it requires invasive biopsies that are uncomfortable for patients and carry risks of tumor cell dissemination. Previous research into non-invasive biomarkers in blood or urine has often been limited by a single-omic focus, providing an incomplete picture of the disease's metabolic landscape.

This study presents a multi-omic framework integrating proteomics and metabolomics across three distinct biological samples: endometrial tissue, urine, and intrauterine brushings. By identifying 13 key metabolic pathways—primarily involving amino acids and nucleotides—the researchers demonstrate that non-invasive samples can mirror the metabolic signatures of cancerous tissue, offering a promising path toward earlier, less invasive diagnosis.

Methods

The study utilized a "multi-omic, multi-biosample" approach, recruiting 44 EC patients and 43 healthy controls. Endometrial tissue, urine, and intrauterine brushings were collected from the cohort to build a comprehensive metabolic map.

The experimental design integrated metabolomics and proteomics across tissue, urine, and intrauterine brushings.

The technical pipeline involved:

  • Metabolomics: Identification of small-molecule metabolites using High-Performance Liquid Chromatography coupled with Quadrupole Time-of-Flight Mass Spectrometry (HPLC-QTOF-MS/MS).
  • Proteomics: Untargeted proteomics (nano-UHPLC-Orbitrap-MS/MS) on tissue samples to identify enzymatic drivers of metabolic changes.
  • Integration: Network analysis (STITCH) and pathway enrichment (KEGG) to link altered proteins to metabolites, identifying significant biological pathways.

Results and Key Insights

The multi-omic analysis revealed that the most significant metabolic shifts in EC occur in amino acid and nucleotide metabolism. These pathways provide the essential building blocks and energy required for rapid tumor proliferation.

PLS-DA scores plot showing distinct metabolic separation between EC patients and healthy controls.

Pathway Dynamics and Diagnostic Potential

Thirteen significant pathways were identified in tissue, including alanine, aspartate, and glutamate metabolism. Many of these pathways feed directly into the TCA cycle, suggesting that EC cells aggressively retool their energy production to support malignancy.

A critical finding was the relationship between sample types. Intrauterine brushings showed metabolic trends similar to tissue (AUC of 0.847), while urine samples often showed opposite trends (AUC of 0.808), likely due to renal clearance and concentration of metabolites as waste.

Furthermore, the integration of proteomics identified 1,445 significantly different proteins in EC tissue, pinpointing specific enzymatic "engines" like BCAT1 and PKM that drive metabolic chaos.

Conclusion

This study provides a comprehensive molecular signature of endometrial cancer, demonstrating that non-invasive biosamples can effectively capture the disease's metabolic state. While limited by a relatively small cohort, the findings suggest that a "liquid biopsy" approach using urine or brushings could eventually supplement or replace invasive diagnostic procedures. Future work will focus on large-scale validation to refine these metabolite panels for clinical use.

Summary updated

Abstract

With multi-omics characterization of multi-biosamples, the metabolomic changes related to EC are illustrated in a pathway-based way. The network of altered metabolites and related proteins provides a comprehensive view of altered metabolism in the endometrial tissue samples. The verification of these critical pathways by using urine and intrauterine brushing samples provides evidence for the possible non-invasive or minimally invasive biopsy for EC diagnosis in the future.
BibTeX
@inproceedings{yi2022multi,
  author = {Runqiu Yi and Liying Xie and Xiaoqing Wang and Chengpin Shen and Xiaojun Chen and Liang Qiao},
  title = {{Multi-Omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer}},
  booktitle = {Frontiers in Oncology},
  year = {2022},
  doi = {10.3389/fonc.2022.861142},
}
Figure